Progenics Pharmaceuticals, Inc. (PGNX) Reports In-Line Q2 EPS
Tweet Send to a Friend
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) reported Q2 EPS of ($0.24) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
